Cargando…
Evaluation of Minimal Residual Disease in Acute Myeloid Leukemia with NPM1 Marker
Background: Minimal residual disease (MRD) tests provide early identification of hematologic relapse and timely management of acute myeloid leukemia (AML) patients. Approximately, 50% of AML patients do not have clonal chromosomal aberrations and categorize as a cytogenetically normal acute myeloid...
Autores principales: | Alizad Ghandforoush, Nasrin, Chahardouli, Bahram, Rostami, Shahrbano, Ghadimi, Habibeh, Ghasemi, Ali, Alimoghaddam, Kamran, Ghavamzadeh, Ardeshir, Nadali, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969559/ https://www.ncbi.nlm.nih.gov/pubmed/27489590 |
Ejemplares similares
-
Concurrent Evaluation of the Expression and Methylation of secreted frizzled-related protein 2 along with beta-catenin Expression in Patients with non-M3 Acute Myeloid Leukemia
por: Mirzaeyan, Fatemeh, et al.
Publicado: (2021) -
Frequency of M287T/AS3MT Single Nucleotide Polymorphism in an Iranian Population
por: Farhid, Fatemeh, et al.
Publicado: (2017) -
Study of SFRP1 and SFRP2 methylation status in patients with de novo Acute Myeloblastic Leukemia
por: Ghasemi, Ali, et al.
Publicado: (2015) -
FLT3-ITD Compared with DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
por: Ardestani, Majid Teremmahi, et al.
Publicado: (2018) -
Incidence and Prognostic Impact of WT-1 Gene Exon7 and 9 Mutations in Acute Promyelocytic Leukemia
por: Nejatifar, Fatemeh, et al.
Publicado: (2022)